SAVA PHARM
Italian-made linear hyaluronic acid joint injections for osteoarthritis, offered to clinics and institutions
Highlights
- Young companyFounded 2026
- New on EvolcAdded 2026-10-22
About SAVA PHARM
SAVA PHARM sells Promovia, a linear hyaluronic acid (sodium hyaluronate, 1500 kDa) for intra-articular injection in osteoarthritis. The range includes 24 mg, 40 mg, 60 mg and 80 mg presentations in 2–4 ml syringes, with indications listed for knee, hip and shoulder joints. The product is manufactured in Italy.
The product is offered to clinics and institutions, and the company has a medical division that handles clinical protocols and institutional distribution. Revenue model details are not published in the source.
SAVA PHARM s.r.o. was founded in 2026 and is registered in Bratislava, Slovakia, where it is headquartered.
Product: Promovia linear hyaluronic acid (sodium hyaluronate, 1500 kDa) joint injections in 24, 40, 60 and 80 mg doses for osteoarthritis.
Jobs at SAVA PHARM
More biotech & pharma companies
TetraDa
Makes bioactive ultrafiltration peptides and premium skincare under three brands, based in Nitra, SlovakiaYoung companyGrowingUNIMED PHARMA
Develops and manufactures ophthalmic medicines and eye-care products for patients and healthcare professionalsProfitableNew on EvolcVULM
Slovak pharmaceutical manufacturer making medicines, food supplements, cosmetics and medical devices under EU GMP rulesProfitableNew on Evolc4Health
Intermediary connecting manufacturers, suppliers and buyers of healthcare, pharma and wellbeing products in EuropeYoung companyNew on EvolcAlfa Medical Team
Outsourced pharmacy sales, marketing and distribution services for foreign pharma and supplement makers in SlovakiaProfitableNew on EvolcAlmirall
Slovak subsidiary of Almirall supplying dermatology prescription and OTC medicines to doctors, pharmacies and clinicsYoung companyGrowing
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Tilda